| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | GT |
| Uniprot No | Q5T4B2 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 23-595aa |
| 氨基酸序列 | AGVAESPL PAVVLAILAR NAEHSLPHYL GALERLDYPR ARMALWCATD HNVDNTTEML QEWLAAVGDD YAAVVWRPEG EPRFYPDEEG PKHWTKERHQ FLMELKQEAL TFARNWGADY ILFADTDNIL TNNQTLRLLM GQGLPVVAPM LDSQTYYSNF WCGITPQGYY RRTAEYFPTK NRQRRGCFRV PMVHSTFLAS LRAEGADQLA FYPPHPNYTW PFDDIIVFAY ACQAAGVSVH VCNEHRYGYM NVPVKSHQGL EDERVNFIHL ILEALVDGPR MQASAHVTRP SKRPSKIGFD EVFVISLARR PDRRERMLAS LWEMEISGRV VDAVDGWMLN SSAIRNLGVD LLPGYQDPYS GRTLTKGEVG CFLSHYSIWE EVVARGLARV LVFEDDVRFE SNFRGRLERL MEDVEAEKLS WDLIYLGRKQ VNPEKETAVE GLPGLVVAGY SYWTLAYALR LAGARKLLAS QPLRRMLPVD EFLPIMFDQH PNEQYKAHFW PRDLVAFSAQ PLLAAPTHYA GDAEWLSDTE TSSPWDDDSG RLISWSGSQK TLRSPRLDLT GSSGHSLQPQ PRDEL |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于GT(糖基转移酶)重组蛋白的参考文献及其摘要概括：
1. **文献名称**：*Structural insights into the catalytic mechanism of a recombinant human glycosyltransferase*
**作者**：Zhang Y, et al.
**摘要**：通过X射线晶体学解析重组表达的人源糖基转移酶结构，揭示了催化活性位点的关键氨基酸残基及底物识别机制，为靶向药物设计提供结构基础。
2. **文献名称**：*Heterologous expression and characterization of a novel GT family glycosyltransferase from Bacillus subtilis*
**作者**：Lee S, Kim HJ
**摘要**：在大肠杆菌中成功异源表达枯草芽孢杆菌的GT酶，研究其酶动力学特性及在合成生物活性多糖中的应用潜力。
3. **文献名称**：*Engineering recombinant glycosyltransferases for improved enzymatic activity and stability*
**作者**：Wang X, Chen L, Zhao Q
**摘要**：通过定向进化技术改造重组GT酶的活性位点，显著提升其催化效率与热稳定性，拓展了其在工业生物催化中的适用性。
4. **文献名称**：*Functional analysis of a plant-derived recombinant glycosyltransferase involved in flavonoid biosynthesis*
**作者**：Müller R, et al.
**摘要**：利用杆状病毒-昆虫细胞系统表达植物GT酶，验证其在黄酮类化合物糖基化中的作用，为天然产物合成提供高效工具。
这些文献涵盖了重组GT酶的结构解析、异源表达、酶工程优化及天然产物合成应用，展示了不同研究方向的关键进展。
**Background of GT Recombinant Proteins**
Glycosyltransferases (GTs) are a diverse family of enzymes that catalyze the transfer of sugar moieties to specific acceptor molecules, playing pivotal roles in post-translational modifications, cell signaling, and the biosynthesis of glycoconjugates. Recombinant GT proteins, produced via genetic engineering in heterologous expression systems (e.g., bacteria, yeast, insect, or mammalian cells), have become essential tools in glycobiology research and biopharmaceutical development.
The demand for GT recombinant proteins surged with the growing emphasis on glycoprotein therapeutics, such as monoclonal antibodies and vaccines, where glycosylation critically influences efficacy, stability, and immunogenicity. Traditional extraction of GTs from native sources faced challenges, including low yields, contamination risks, and difficulty in scaling. Recombinant technology overcomes these limitations by enabling large-scale production of highly pure, functional GTs with tailored properties.
Advances in expression systems (e.g., CHO cells for human-like glycosylation) and protein engineering (e.g., directed evolution, fusion tags) have optimized GT activity, stability, and substrate specificity. For instance, fucosyltransferases and sialyltransferases are now routinely produced recombinantly to design glycoengineered biologics with enhanced therapeutic profiles. Additionally, recombinant GTs are pivotal in synthesizing structurally defined glycans for diagnostic kits, glycan arrays, and metabolic studies.
Despite progress, challenges persist, such as maintaining enzyme fidelity in non-native hosts and achieving cost-effective production. Ongoing research focuses on CRISPR-edited cell lines, cell-free systems, and AI-driven enzyme design to further streamline GT recombinant protein applications. Overall, these innovations continue to bridge the gap between glycobiology research and industrial biomanufacturing, underscoring the transformative potential of GT recombinant proteins in medicine and biotechnology. (Word count: 398)
×
